Steve Schonfeld’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
SL
Steve Schonfeld's ORIC Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 10,244 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #2444 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ORIC as recently as Q4 2025.
Steve Schonfeld first reported a position in ORIC in Q1 2022 and has held it in 7 quarters since. The position peaked at $5.85M in Q4 2024. 191 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Steve Schonfeld held 10,244 shares of Oric Pharmaceuticals worth $138K as of Q3 2026.
- Oric Pharmaceuticals was a new Steve Schonfeld position in Q3 2026.
- Oric Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2444 holding.
- Steve Schonfeld first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
- Steve Schonfeld's Oric Pharmaceuticals position peaked at $5.85M in Q4 2024.
- 191 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.